Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder of reproductive-agedwomen. Women with PCOS exhibit poor reproductive performance and are at increased risk forendometrial hyperplasia. During the last funding periods, we described specific derangements in theendometrium of women with PCOS, including high levels of androgen receptors (AR), estrogen receptors(ER), and the pi6o coactivators. In this proposal, we are focused mainly on the role of estrogen andepidermal growth factor (EGF) in normal and PCOS endometrium. Estrogen has both positive andnegative effects on implantation. Progesterone limits the action of estrogen through down-regulation ofER and up-regulation of enzymes that metabolize estrogen at the time of embryo attachment. Persistentestrogen actions inhibit expression of specific proteins thought to be essential for normal implantation.EGF family proteins, on the other hand, stimulate expression of implantation related proteins. Wehypothesize that estrogen, acting through membrane associated pathways, stimulates the action of EGFfamily ligands. We will study for the first time a novel membrane-bound estrogen receptor, GPRso, inhuman endometrial epithelium and define the EGF-mediated signaling pathways elicited by estrogenbinding to this G-protein coupled receptor.
In Aim i. we will identify factors that influence the estrogenresponse during the menstrual cycle in normal and PCOS endometrium.
In Aim 2. we will describe keyeffects of estrogen on normal and PCOS endometrium by determining the membrane and nuclearreceptor mechanisms through which estrogen regulates the expression of estrogen response factors andother target genes.
In Aim a. we will dissect the signaling pathways used by estrogen in regulating theearly response gene, Cyr6i. Finally, in Aim 4. we will use in vivo and in vitro models to characterize theresponsiveness to progesterone and estrogen and determine the functions of epithelial and stromal cellsfrom normal and PCOS endometrium to identify paracrine factors that may underlie the regulatorydysfunction in PCOS. The experiments will utilize molecular analysis of a combination of humanendometrial cell lines, primary cultures of human endometrial cells and human tissue explant models toachieve these aims. Understanding normal and abnormal mechanisms of sex steroid action in humanendometrium will provide important insights toward the development, of improved infertility treatmentsand contraceptive approaches.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54HD035041-11
Application #
7315892
Study Section
Special Emphasis Panel (ZHD1-DRG-D (05))
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
11
Fiscal Year
2007
Total Cost
$146,585
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Danshina, Polina V; Qu, Weidong; Temple, Brenda R et al. (2016) Structural analyses to identify selective inhibitors of glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme. Mol Hum Reprod 22:410-26
Franasiak, Jason M; Holoch, Kristin J; Yuan, Lingwen et al. (2014) Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ???3 testing in women with unexplained infertility. Fertil Steril 101:1724-31
Su, Shifeng; Minges, John T; Grossman, Gail et al. (2013) Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins. J Biol Chem 288:24809-24
Lenhart, Patricia M; Broselid, Stefan; Barrick, Cordelia J et al. (2013) G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol 51:191-202
Minges, John T; Su, Shifeng; Grossman, Gail et al. (2013) Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers. J Biol Chem 288:1939-52
Askew, Emily B; Minges, John T; Hnat, Andrew T et al. (2012) Structural features discriminate androgen receptor N/C terminal and coactivator interactions. Mol Cell Endocrinol 348:403-10
Plante, Beth J; Lessey, Bruce A; Taylor, Robert N et al. (2012) G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod Sci 19:684-93
Su, Shifeng; Blackwelder, Amanda J; Grossman, Gail et al. (2012) Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation. J Biol Chem 287:34809-24
Goodson, Summer G; Qiu, Yunping; Sutton, Keith A et al. (2012) Metabolic substrates exhibit differential effects on functional parameters of mouse sperm capacitation. Biol Reprod 87:75
Lagarde, William H; Blackwelder, Amanda J; Minges, John T et al. (2012) Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation. J Biol Chem 287:10905-15

Showing the most recent 10 out of 147 publications